MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202311047072 A) filed by Birla Institute Of Technology & Science, Pilani, Rajasthan, on Jan. 13, 2024, for 'drug eluting conjunctival device for the treatment of uveitis.'
Inventor(s) include Nirmal J; and Velmurugan K.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a drug-eluting conjunctival device for treating uveitis and other such inflammatory condition of the eye. The invention is based on the use of nanomicelles loaded into drug eluting conjunctival device to enhance the solubility of the drug apremilast....